The CRF neuron: immunocytochemical study.
In the central nervous systems of several species belonging to different vertebrate classes, immunocytochemical stainings with an antiserum to ovine CRF 41 show multiple location of CRF perikarya and various areas containing CRF fibres and terminals. These stainings reflect species and interspecies functional adaptations of the CRF neurones which constitute a prominent hypothalamo-infundibular system involved in pituitary gland control, and also interneurone systems as attested to by extrahypothalamic perikarya and by CRF perisomatal endings in several brain areas. Perikarya of the hypothalamo-infundibular system are mainly packed in the paraventricular nucleus (mammals, birds) or in homologous areas, e.g.: paraventricular organ (turtle) where they are CSF-contacting neurones and preoptic nucleus (amphibians, fishes). In all species but fish, CRF fibres end in the median eminence (ME) against portal vessels. In fish, CRF processes terminate in the peripheral areas of proadenohypophyseal neurodigitations, close to corticotrophs. In all species these stainings are abolished by preabsorption of the serum by CRF. In fishes, reptiles and amphibians they are also suppressed by urotensin I, which is thought to be the teleost's CRF. Adrenalectomy experiments in the rat provided evidence for a corticosteroid regulation of ME CRF: short term (12-24 hr) adrenalectomy induces a complete depletion of CRF immunoreactivity followed by a secondary accumulation (5-20 days). This biphasic evolution is prevented by a dexamethasone replacement therapy. Inhibitory role of catecholamines on CRF release was indicated by: disappearance of ME CRF, induced by a single reserpine injection and suppression of this effect by monoamineoxidase inhibitor (pargyline or tranylcypromine) pretreatment. CRF fibres were first observed in the ME at the 16th week of fetal development in the human, and at the 18th day in the rat fetus. Thus, immunoreactive CRF system develops later than pituitary corticotrophs.
D000315:Adrenalectomy; D000663:Amphibians; D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism; D001717:Birds; D001921:Brain / Q000196:embryology / Q000378:metabolism; D002415:Cats; D003346:Corticotropin-Releasing Hormone / Q000276:immunology / Q000378:metabolism*; D004285:Dogs; D000939:Epitopes / Q000276:immunology; D005399:Fishes; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs; D006651:Histocytochemistry; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D007106:Immune Sera / Q000276:immunology; D009411:Nerve Endings / Q000378:metabolism; D009412:Nerve Fibers / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D010455:Peptides / Q000276:immunology; D051381:Rats; D012104:Reptiles; D012377:Rodentia; D012756:Sheep; D013045:Species Specificity; D014018:Tissue Distribution
D000939:Epitopes; D007106:Immune Sera; D010455:Peptides; D003346:Corticotropin-Releasing Hormone